Valuation (74%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 11.68 | N/A |
| PEG Ratio (TTM) | 5.28 | N/A |
| P/S Ratio (TTM) | 2.54 | N/A |
| P/B Ratio (TTM) | 1.39 | N/A |
| P/FCF Ratio (TTM) | 2.61 | N/A |
| Price to 5YR AVG Earnings Ratio | 15.23 | N/A |
| Price to 5YR AVG FCF Ratio | 9.83 | N/A |
Profitability (55%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 1.28% | N/A |
| ROE (TTM) | 12.57% | N/A |
| Net Profit Margin (TTM) | 21.68% | N/A |
| ROIC 5YR AVG | 10.62% | N/A |
Growth (87%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 3.99% | 31.42% | 20.57% |
| Revenue | 13.38% | 15.43% | 13.81% |
| Net Income | 4.13% | 33.97% | 23.34% |
| Cash Flow | 2,996.12% | 14.77% | 59.18% |
Health (68%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 150.64 | N/A |
| Quick Ratio (TTM) | 150.64 | N/A |
| D/E Ratio (TTM) | 0.68 | N/A |
| Interest Coverage (TTM) | 0.41 | N/A |
| Piotroski F-Score | 6 | N/A |
| Altman Z-Score | 0.44 | N/A |
| LTL to 5YR AVG FCF | 5.17 | N/A |
| Shares Outstanding Growth 5YR AVG | 2.58% | N/A |